Caliber Wealth Management (Kansas)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Caliber Wealth Management (Kansas)'s BMY Position: Q3 2025 in Review
Caliber Wealth Management (Kansas) sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 7,257 shares — an estimated $336K sold.
Caliber Wealth Management (Kansas) first reported a position in BMY in Q1 2025 and held it in 2 quarters. The position peaked at $336K in Q2 2025. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.
- Caliber Wealth Management (Kansas) reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
- Caliber Wealth Management (Kansas) sold 7,257 Bristol-Myers Squibb shares in Q3 2025, an estimated $336K.
- Caliber Wealth Management (Kansas) first reported a position in Bristol-Myers Squibb in Q1 2025 and held it in 2 quarters.
- Caliber Wealth Management (Kansas)'s Bristol-Myers Squibb position peaked at $336K in Q2 2025.
- 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.
Based on Caliber Wealth Management (Kansas)'s 13F filing for Q3 2025, filed 5 Nov 2025.